HADV (Health Advance) ROE %: -11.04% (As of Sep. 2017)


What is Health Advance ROE %?

Health Advance HADV ROE % is -11.04% as of Sep. 2017.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Health Advance's annualized net income for the quarter that ended in Sep. 2017 was $-0.30 Mil. Health Advance's average Total Stockholders Equity over the quarter that ended in Sep. 2017 was $2.68 Mil. Therefore, Health Advance's annualized ROE % for the quarter that ended in Sep. 2017 was -11.04%.

The historical rank and industry rank for Health Advance's ROE % or its related term are showing as below:

HADV's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 5.84
* Ranked among companies with meaningful ROE % only.

Health Advance  (OTCPK:HADV) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2017 )
=Net Income/Total Stockholders Equity
=-0.296/2.682
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.296 / 0)*(0 / 2.9775)*(2.9775 / 2.682)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*1.1102
=ROA %*Equity Multiplier
=N/A %*1.1102
=-11.04 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2017 )
=Net Income/Total Stockholders Equity
=-0.296/2.682
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-0.296 / -0.296) * (-0.296 / -0.296) * (-0.296 / 0) * (0 / 2.9775) * (2.9775 / 2.682)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 1 * N/A % * 0 * 1.1102
=-11.04 %

Note: The net income data used here is four times the quarterly (Sep. 2017) net income data. The Revenue data used here is four times the quarterly (Sep. 2017) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.

Health Advance ROE % Related Terms

Health Advance ROE % Historical Data

* Premium members only.

The historical data trend for Health Advance's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Advance ROE % Chart

Health Advance Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15
ROE %
-323.81 0.00 0.00 0.00 0.00

Health Advance Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Sep17
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -11.04

HADV vs MYDP, HEWA, RXMD: ROE % Comparison

For the Pharmaceutical Retailers subindustry, Health Advance's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Health Advance ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Advance's ROE % distribution charts can be found below:

* The bar in red indicates where Health Advance's ROE % falls into.


Health Advance ROE % Calculation

Health Advance's annualized ROE % for the fiscal year that ended in Jul. 2015 is calculated as

ROE %=Net Income (A: Jul. 2015 )/( (Total Stockholders Equity (A: Jul. 2014 )+Total Stockholders Equity (A: Jul. 2015 ))/ count )
=-0.068/( (-0.105+-0.13)/ 2 )
=-0.068/-0.1175
=N/A %

Health Advance's annualized ROE % for the quarter that ended in Sep. 2017 is calculated as

ROE %=Net Income (Q: Sep. 2017 )/( (Total Stockholders Equity (Q: Apr. 2017 )+Total Stockholders Equity (Q: Sep. 2017 ))/ count )
=-0.296/( (0+2.682)/ 1 )
=-0.296/2.682
=-11.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2017) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -11.04% mean?
Health Advance (HADV) has a ROE % of -11.04% as of Sep. 2017. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Health Advance and its competitors.
Is Health Advance's ROE % too high?
Health Advance's current ROE % is -11.04%.
How does Health Advance's ROE % compare to MYDP and HEWA?
Health Advance's ROE % of -11.04% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROE % is 5.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Health Advance and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Advance's current ROE % is -11.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Advance stock overvalued right now?
Health Advance (HADV) has a current ROE % of -11.04%. The current ROE % is -11.04%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Health Advance (HADV), the current ROE % is -11.04% as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Advance Business Description

Address 9131 Keele Street, Suite A4, Vaughan, ON, CAN, L4K 0G7
Health Advance Inc is engaged in the retail domain. The Company is focused on products that are oriented to health and wellness. The first example of this is a proprietary CBD-infused wine beverage. The company is in the analysis stage for Immune boosting nutraceuticals, and human wellness products.